A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results-Reference-Cited by-同舟云学术

A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results

Published:2010-01-19 Issue:3 Volume:106 Page:349-354
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Pruthi Raj S.,Nielsen Matthew,Heathcote Samuel,Wallen Eric M.,Rathmell W. Kim,Godley Paul,Whang Young,Fielding Julia,Schultz Heather,Grigson Gayle,Smith Angela,Kim William

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2009.09101.x/fullpdf

Reference30 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta. T1, and Tis); 2007 update;Hall;J Urol,2007

3. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

4. Systemic chemotherapy for patients with bladder cancer - current controversies and future directions;Chester;Cancer Treat Rev,2004

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis;Drug Resistance Updates;2024-09

2. Research Progress of Neoadjuvant Chemotherapy in Advanced Bladder Cancer;annals of urologic oncology;2024-08-20

3. Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report;Current Oncology;2024-07-14

4. Landscape of targeted therapies for advanced urothelial carcinoma;Exploration of Targeted Anti-tumor Therapy;2024-06-21

5. Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer;Cancers;2024-04-17